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tion and its high metabolisation in glucuronides (GC), suggesting that these
metabolites are susceptible to express HT biologicial activity in vivo. Our
objective was to compare the vasorelaxant effect of Res, HT and GC on iso-
lated aortic from young males Wistar rats (3months), old Wistar and GK rats
(14 months), in presence or not of t-BOOH-induced oxidative stress (1mM;
30min). No vasorelaxant effect of the polyphenols was observed in young or
old males Wistar rats. However, in old GK rats, Res and GC had significant
vasorelaxant effect. In response to t-BOOH-induced oxidative stress, HT and
RES protected the aortic rings of young Wistar rats (p < 0.05). However, dif-
ferent maximal relaxation was found between HT + t-BOOH, Res + t-BOOH
and Control (72.5 ± 2.8%, 76.1% ± 7.7% vs 88.8 ± 0.7% ; p<0.05). The sen-
sibility to Ach (EC50) was altered negatively in Res + t-BOOH and t-BOOH
in comparison of Control (2084.6 ± 1687 nM, 2983.5 ± 1110 nM vs
66.9±10.7 nM). The protective effect of HT and RES against the acute effect
of t-BOOH-induced oxidative stress in a normal context tends to confirm our
results in old GK rats, highlighting an effect of these polyphenols only in a
pro-oxidant context.
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Branched-chain amino acids like leucine induce insulin resistance in
muscle and adipose tissues. The mechanism explaining leucine action
involves mTOR/p70S6K signaling. This pathway is activated by leucine and
is implicated in the stimulation of an insulin negative feedback loop.
Knowing that insulin-resistance participates in diabetic cardiomyopathy, we
were interested in studying leucine action in cardiomyocytes. Primary
cultured adult rat cardiomyocytes were pretreated with different concentra-
tions of leucine (1 to 10mM) during different periods of time (up to 20h)
before being exposed to insulin (3x10-9M, 30min). Insulin increased glu-
cose transport. This correlated with the increase of PKB and AS160 phos-
phorylation, both known to regulate GLUT4 translocation to the plasma
membrane allowing glucose uptake. 1h pre-incubation with leucine stimu-
lated mTOR/p70S6K pathway. This is accompanied by a decrease in PKB
and AS160 phosphorylation but, surprisingly, insulin-stimulated glucose
uptake was preserved. On the other hand, a longer incubation (14h) with leu-
cine induced a drastic decrease in glucose transport. The mTOR/p70S6K
inhibitor rapamycin did not prevent this inhibition. The non-metabolized
leucine analog BCH had no effect on the insulin-induced glucose uptake. By
contrast, intermediates of leucine catabolism, alpha-ketoisocaproate and
ketone bodies inhibited glucose uptake similarly to leucine. This inhibition
is clearly independent of insulin signaling because leucine also inhibited
basal glucose transport and glucose uptake stimulated by the insulin-unre-
lated pathway involving AMPK. The leucine-mediated inhibition of glucose
transport resulted from the inhibition of GLUT4 translocation. The exact
molecular mechanism downstream leucine’s metabolites and responsible for
the inhibition of GLUT4 translocation and glucose uptake is under investi-
gation. Leucine catabolism reduces cardiac glucose transport independently
of insulin signaling by an undefined mechanism.
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Background/Objective: Despite piceatannol is a polyphenol belonging the
stilbene family as resveratrol, only very scarce studies have adressed its
effects in obesity. Thus, our objective was to analyze the potential effects of
piceatannol on cardiac tissue remodelling associated with the development of
diabetes and obesity in Zucker rats (fa/fa) rats. This study was part of the
POLYFrEsNOL study granted by the REFBIO network.
Methods: Zucker rats aged 6 weeks purchased from Charles River
(France) were placed in an air-conditioned room (22Cº ± 2°C with a 12 h light
– dark cycle. They were fed with a normal diet and received 15 mg/kg (P15,
n=10) or 45 mg/kg (P45, n=10) of piceatannol or vehicle (Ctl, n=10) during
42 days. After euthanasia, hearts were removed for histomorphological anal-
ysis including measurement of cardiomyocyte size (membranes were stained
using WGA) and quantification of fibrosis (trichrome of Masson) as well as
measurement of the cardiac expression of ephrin-B1 (western-blot). Data are
presented as mean ± SD and were analyzed using one-way ANOVA.
Results: Piceatannol, whatever its dosage, failed to prevent the weight
increase induced by HFD (Ctl: 170±32 g, P15: 168±23 g, P45: 169±26 g). No
differences in heart weight/body weight ratio (mg/g) was noticed (Ctl:
2.74±0.20, P15: 2.55±0.20, P45: 2.58±0.22, NS). Piceatannol (15 and 45 mg/kg)
failed to reduce cardiomyocyte hypertrophy or heart fibrosis deposition. A
significant increase in ephrin-B1 expression (p<0.01 vs Ctl) in whole heart
tissue was noticed in the P45 group but not in the P15 group (Fig 1).
Conclusion: Piceatannol does not prevent cardiac tissue remodeling asso-
ciated with obesity and diabetes in this model. However, the increase in
ephrin-B1 expression suggests that it could have some protective properties
against cardiomyocyte lateral membrane remodeling. This finding would jus-
tify new studies investigating its effect on lateral membrane structure using
electron microscopy.
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